Skip to content Skip to sidebar Skip to footer
telix
Why Telix (ASX:TLX) Fell 20% After FDA News – And What Investors Should Know
When expectations fall short, sentiment can shift in an instant. That is exactly what happened with Telix Pharmaceuticals (ASX: TLX) after the company received an unexpected setback from the U.S. Food and Drug Administration.  TLX had applied for approval of TLX250-CDx, an innovative imaging agent designed to help doctors more accurately diagnose kidney…
Weebit
Inside Weebit Nano’s 333% Revenue Surge and the Future of ReRAM
Is This the Inflection Point Investors Have Been Waiting For? Weebit Nano (ASX:WBT) opened this morning with a 6% gain, a move that signals growing confidence among investors in the company’s ReRAM memory technology. The rise comes on the back of a strong annual report that showed revenues climbing to A$4.4 million, representing year-on-year growth…
nanosonics
Why Investors Are Watching Nanosonics (ASX: NAN) After a Strong Earnings Surge
Is CORIS the Catalyst for Nanosonics’ (ASX: NAN) Next Phase of Expansion? Nanosonics (ASX: NAN) has caught the market’s attention, with its share price climbing 14 percent over the past week as excitement built ahead of its full-year results.  The earnings release did not disappoint, giving investors fresh confidence in the company’s long-term growth story. At…

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here